MA De Vera, V Bhole, LC Burns… - British journal of clinical …, 2014 - Wiley Online Library
Aims While suboptimal adherence to statin medication has been quantified in real‐world patient settings, a better understanding of its impact is needed, particularly with respect to …
HJ Burstein, S Temin, H Anderson… - Journal of clinical …, 2014 - ascopubs.org
Purpose To update the ASCO clinical practice guideline on adjuvant endocrine therapy on the basis of emerging data on the optimal duration of treatment, particularly adjuvant …
RJ Simpson Jr, P Mendys - Journal of clinical lipidology, 2010 - Elsevier
BACKGROUND: In clinical practice, medication adherence and persistence are important for disease management and can significantly improve outcomes and enhance the quality of …
TR Bates, VM Connaughton… - Expert opinion on …, 2009 - Taylor & Francis
Background: Hypercholesterolemia is a major risk factor for atherosclerosis and cardiovascular disease, the leading cause of death worldwide. In the last twenty years …
P Conthe, EM Contreras, AA Pérez, BB García… - Revista clínica …, 2014 - Elsevier
Las enfermedades crónicas de larga duración poseen una elevada mortalidad y afectan por igual a ambos sexos. La falta de adherencia a las recomendaciones terapéuticas continúa …
JP Greving, FLJ Visseren, GA De Wit, A Algra - Bmj, 2011 - bmj.com
Objective To assess the cost-effectiveness of low dose statins for primary prevention of vascular disease, incorporating current prices, non-adherence (reduced clinical efficacy …
Introduction Previous research has shown that statin adherence for the primary prevention of CVD is lower compared to secondary prevention populations. Therefore the aim of this …
YH Gomez Sandoval, M V. Braganza… - Current …, 2011 - benthamdirect.com
Hypercholesterolemia is a major risk factor for cardiovascular disease (CVD), the leading cause of death worldwide. Since the late 1980s, statins have emerged as effective lipid …
Background Statins are currently the preferred pharmacological therapy in individuals with familial hypercholesterolemia (FH) with the aim to prevent premature atherosclerosis. In …